Keynote Financial Services’s Gilead Sciences GILD Stock Holding History

Keynote Financial Services’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.66M	Sell	11,902 -41	-0.3%	-$5.74K	0.88%	34
2025 Q4	$1.47M	Sell	11,943 -64	-0.5%	-$7.78K	0.82%	34
2025 Q3	$1.33M	Sell	12,007 -385	-3%	-$43.8K	0.8%	34
2025 Q2	$1.37M	Hold	12,392	–	–	0.92%	30
2025 Q1	$1.39M	Sell	12,392 -130	-1%	-$13.4K	0.99%	29
2024 Q4	$1.16M	Sell	12,522 -55	-0.4%	-$4.95K	0.89%	33
2024 Q3	$1.05M	Buy	12,577 +141	+1%	+$10.8K	0.81%	39
2024 Q2	$853K	Buy	12,436 +895	+8%	+$59.7K	0.71%	44
2024 Q1	$845K	Buy	+11,541	New	+$887K	0.71%	43

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Keynote Financial Services's GILD Position: Q1 2026 in Review

Keynote Financial Services reduced its Gilead Sciences (GILD) stake by 0.34% in Q1 2026, selling an estimated $5.74K and leaving 11,902 shares worth $1.66M. The position accounts for 0.88% of the portfolio, ranked #34.

Keynote Financial Services first reported a position in GILD in Q1 2024 and has held it in 9 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Keynote Financial Services held 11,902 shares of Gilead Sciences worth $1.66M as of Q1 2026.
Keynote Financial Services sold 41 Gilead Sciences shares in Q1 2026, an estimated $5.74K.
Gilead Sciences made up 0.88% of Keynote Financial Services's portfolio in Q1 2026, its #34 holding.
Keynote Financial Services first reported a position in Gilead Sciences in Q1 2024 and has held it in 9 quarters since.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Keynote Financial Services's 13F filing for Q1 2026, filed 13 May 2026.